Search Results

ERS Genomics Limited, the CRISPR licensing company, announced the appointment of John E Milad as CEO, with immediate effect.

ERS Genomics Limited, the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, announced a non-exclusive CRISPR/Cas9 license agreement.

Ricoh Company, Ltd. announced a non-exclusive licensing agreement in the USA and Japan with ERS Genomics Limited for access to the foundational CRISPR/Cas9 genome editing technology patents managed by ERS Genomics.

ERS Genomics Limited, the CRISPR licensing Company, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr Emmanuelle Charpentier, and StemSight Oy, a biotechnology company developing stem cell based therapies for corneal blindness, announced a non-exclusive CRISPR/Cas9 license agreement.

AI-Powered Genomic Mapping Could Revolutionize Treatment of Rare Genetic Diseases

Dovetail Genomics, a pioneering leader in the development of genomic solutions, announced a new strategic partnership with Australian Genome Research Facility.

ERS Genomics Limited is pleased to announce ATLATL Innovation Centre as its non-exclusive agent for licensing ERS’ intellectual property for commercial and/or research use in China.